Entropy Technologies’s Takeda Pharmaceutical TAK Stock Holding History

Entropy Technologies’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	+65,587	New	+$1.09M	0.04%	493
2026 Q1	–	Sell	-42,831	Closed	-$668K	–	1152
2025 Q4	$668K	Buy	42,831 +21,756	+103%	+$311K	0.04%	484
2025 Q3	$309K	Buy	+21,075	New	+$313K	0.02%	651
2025 Q2	–	Sell	-10,483	Closed	-$156K	–	1010
2025 Q1	$156K	Buy	+10,483	New	+$147K	0.02%	648

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Entropy Technologies's TAK Position: Q2 2026 in Review

Entropy Technologies opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 65,587 shares worth $1.05M. The stake represents 0.04% of the portfolio and ranks #493 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in TAK as recently as Q4 2025.

Entropy Technologies first reported a position in TAK in Q1 2025 and has held it in 4 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Entropy Technologies held 65,587 shares of Takeda Pharmaceutical worth $1.05M as of Q2 2026.
Takeda Pharmaceutical was a new Entropy Technologies position in Q2 2026.
Takeda Pharmaceutical made up 0.04% of Entropy Technologies's portfolio in Q2 2026, its #493 holding.
Entropy Technologies first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 4 quarters since.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.